butabarbital decreases outcomes of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Coadministration of CYP3A4 inducers may well lessen sufentanil concentrations and efficacy, quite possibly precipitating withdrawal syndrome in individuals which have designed physical dependence to sufentanil. Di… Read More